Health Condition 1: I509- Heart failure, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age = 18 years 2. Recent hospitalization (within 4 weeks of enrollment) for HF with IV diuretic use 3. Echocardiography data with EF measurements available in the last 6 months and after HF diagnosis 4. Established outpatient care at the participating sites 5. Eligible to receive at least 2 of the 4 GDMT classes (ACEi/ARB/ARNi, Beta-blockers, MRA, and SGLT2i) for HFrEF and at least one of the three (ARB/ARNI, MRA, SGLT2i) for HFpEF 6. Not on Target GDMT for all of the eligible GDMT classes 7. >12 months of expected survival 8. Comfortable with spoken and written English communication
Exclusion criteria
Exclusion criteria: 1. Under consideration for or recipient of advanced heart failure therapies (LVAD, Transplant) 2. Current or anticipated use of home intravenous inotrope therapy. 3. Unwilling or unable to perform all study related procedures (wear watch, take measurements and maintain daily logs) 4. Post-discharge placement in nursing, rehabilitation, or long-term care facility 5. Planned (within next 6 months) surgery 6. Inability to provide written consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Multiple exploratory outcomes will be assessed. 1. HF-Collaboratory Score assessed at the beginning and end of the study. 2. Proportion of patients with HFpEF on MRA, and SGLT2i 3. Proportion of patients with (CHADS2VASC 2) with Atrial fibrillation on anticoagulation. 4. Changes in NT-proBNP, and KCCQ throughout the study period.Timepoint: 24 Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1 HF-Collaboratory Score assessed at the beginning and end of the study 2 Proportion of patients with HFpEF on MRA and SGLT2i 3 Proportion of patients with CHADS2VASC greater than 2 with Atrial fibrillation on anticoagulation 4 Changes in NT proBNP and KCCQ throughout the study periodTimepoint: As per study protocol. | — |
Countries
India
Contacts
Manipal Hospital